(117 days)
No
The summary explicitly states "No data processing is done by the Hypervisor IX Monitoring System for data received from compatible monitors." and there are no mentions of AI, ML, or related concepts in the document. The performance studies focus on functional, system level, and wireless testing, not AI/ML performance metrics.
No
The device is described as a monitoring system that displays, stores, prints, and transfers patient data without performing data processing, and its intended use is for remote patient monitoring. It does not provide any therapeutic intervention.
Yes
Explanation: The "Hypervisor IX Monitoring System" is described as a networked patient monitoring system that receives, displays, stores, and processes physiological data (ECG, SpO2, Heart Rate, Arrhythmia analysis, QT monitoring, and ST Segment Analysis) from compatible monitors and telemetry systems. This data analysis and presentation to clinicians for patient monitoring and alarm generation indicates a diagnostic function for understanding the patient's physiological state.
No
The device description explicitly lists hardware components like "Central Station," "View Station," "Work Station," and "Telemetry Systems (TMS 6016, Telepak-608, TMS60)". These are physical devices, not just software.
Based on the provided text, the Hypervisor IX Monitoring System is not an In Vitro Diagnostic (IVD) device.
Here's why:
- IVD Definition: In Vitro Diagnostics are devices intended for use in the collection, preparation, and examination of specimens taken from the human body (such as blood, urine, or tissue) to obtain information for diagnostic or monitoring purposes.
- Hypervisor IX Monitoring System Function: The description clearly states that the Hypervisor IX Monitoring System is a networked patient monitoring system that receives, displays, stores, prints, and transfers physiological data (ECG, SpO2, Heart Rate, etc.) directly from compatible physiological monitors and telemetry systems connected to the patient. It does not process or analyze specimens taken from the body.
- Intended Use: The intended use focuses on remote patient monitoring, real-time viewing of clinical data, historical review, and data management, all based on physiological signals.
Therefore, the Hypervisor IX Monitoring System falls under the category of patient monitoring systems, not In Vitro Diagnostics.
N/A
Intended Use / Indications for Use
The indications for use of the Hypervisor IX Monitoring System include:
- Real time viewing of patient clinical data and alarms ●
- Storage and Historical review of patient clinical data and alarms ●
- Printing of real time and historical patient data ●
- Configuration of local settings as well as synchronizing settings across the network to a remote device
- Transfer of patient clinical data and settings between several CentralStations ●
The Hypervisor IX Monitoring System is a networked patient monitoring system intended for use in a fixed location, installed in a hospital or clinical environment to provide clinicians remote patient monitoring. The network connections between the various devices can be any combination of Ethernet (Wired), Wireless WiFi (WLAN), and Wireless WMTS.
The Hypervisor IX Monitoring System supports one or more Mindray compatible physiological monitors and will display, store, print, and transfer information received from the compatible monitors; The Hypervisor IX Monitoring System supports bi-directional configuration of the compatible monitors. No data processing is done by the Hypervisor IX Monitoring System for data received from compatible monitors.
The Hypervisor IX Monitoring System includes several Telemetry monitoring subsystems all of which operate in the 608M WMTS frequency range within a defined coverage area. All of the supported telemetry systems transmit data to the CentralStation for processing, display, and alarm.
- . The TMS-6016 transmitter is intended for use on Adult and Pediatric patients to monitor ECG and SpO2 physiological data. The CentralStation will support ECG, Heart Rate, SpO2, Pulse Rate, Arrhythmia analysis, QT monitoring, and ST Segment Analysis for the TMS-6016.
- . The Panorama Telepack-608 transmitter is intended for use on Adult patients to monitor ECG and SpO2 physiological data. The CentralStation will support ECG, Heart Rate, SpO2, Pulse Rate, Arrhythmia analysis, QT monitoring, and ST Segment Analysis for the Panorama Telepack-608.
- The TMS60 transmitter is intended for use on Adult and Pediatric patients to monitor ● ECG and SpO2 physiological data. The physiological data can be reviewed locally on the display of the transmitter. The CentralStation will support ECG, Heart Rate,
SpO2, Pulse Rate, Arrhythmia analysis, QT monitoring, and ST Segment Analysis for the TMS60.
The Hypervisor IX Monitoring System is intended for use in a hospital or other clinical environment under the direct supervision of a licensed healthcare practitioner.
Product codes (comma separated list FDA assigned to the subject device)
MSX, DRQ, MHX
Device Description
The Hypervisor IX Monitoring System is a networked patient monitoring system intended for use in a fixed location, installed in a hospital or clinical environment to provide clinicians remote patient monitoring. The network connections between the various devices can be any combination of Ethernet (Wired), Wireless WiFi (WLAN), and Wireless WMTS.
The Hypervisor IX Monitoring System supports one or more Mindray compatible physiological monitors and will display, store, print, and transfer information received from the compatible monitors; The Hypervisor IX Monitoring System supports bi-directional configuration of the compatible monitors. No data processing is done by the Hypervisor IX Monitoring System for data received from compatible monitors.
The Hypervisor IX Monitoring System includes three telemetry monitoring systems all of which operate in the 608M WMTS frequency range within a defined coverage area. All of the supported telemetry systems transmit data to the CentralStation for processing, display, and alarm.
The Hypervisor IX Monitoring System consists the following components:
-
- Central Station
-
- View Station
-
- Work Station
-
- Telemetry Systems (TMS 6016, Telepak-608, TMS60)
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Adult and Pediatric patients
Intended User / Care Setting
hospital or other clinical environment under the direct supervision of a licensed healthcare practitioner. / fixed location, installed in a hospital or clinical environment
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
To establish the substantial equivalence of the Hypervisor IX Monitoring System, Mindray conducted functional and system level testing on the subject device. The testing provided an evaluation of the performance of the device relevant to each of the differences between the subject device and the predicate device. The functional and system level testing showed that the devices continue to meet specifications and the performance of the device is equivalent to the predicate.
Mindray has conducted testing to ensure the subject device meets relevant consensus standards.
Mindray conducted Wireless functionality testing to ensure the performance of the Hypervisor IX Monitoring System meets wireless specifications and is equivalent to the predicate device.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
K072235, K070791, K092449, K143195, K132662, K132038, K143195, K062098, K062098, K020550, K091834, K132026, K132036, K142601, K101521
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.2300 Cardiac monitor (including cardiotachometer and rate alarm).
(a)
Identification. A cardiac monitor (including cardiotachometer and rate alarm) is a device used to measure the heart rate from an analog signal produced by an electrocardiograph, vectorcardiograph, or blood pressure monitor. This device may sound an alarm when the heart rate falls outside preset upper and lower limits.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo features a stylized graphic of three human profiles facing right, stacked on top of each other. The profiles are rendered in a dark color, creating a silhouette effect. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the graphic.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
July 6, 2015
Shenzhen Mindray Bio-medical Electronics Co., Ltd Yanhong Bai Manager Regulatory Affairs Mindray Building, Kenji 12th Road South, Hi-tech Industrial Park, Nanshan Shenzhen, 518057 CN
Re: K150632
Trade/Device Name: Hypervisor IX Monitoring System Regulation Number: 21 CFR 870.2300 Regulation Name: Cardiac Monitor (Including Cardiotachometer and Rate Alarm) Regulatory Class: Class II Product Code: MSX, MHX, DRQ Dated: March 9, 2015 Received: March 11, 2015
Dear Yanhong Bai:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply
1
with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely vours
for Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K150632
Device Name Hypervisor IX Monitoring System
Indications for Use (Describe)
- The indications for use of the Hypervisor IX Monitoring System include:
- · Real time viewing of patient clinical data and alarms
- · Storage and Historical review of patient clinical data and alarms
- · Printing of real time and historical patient data
- · Configuration of local settings as well as synchronizing settings across the network to a remote device
- · Transfer of patient clinical data and settings between several CentralStations
The Hypervisor IX Monitoring System is a networked patient monitoring system intended for use in a fixed location, installed in a hospital or clinical environment to provide clinicians remote patient monitoring. The network connections between the various devices can be any combination of Ethernet (Wireless WiFi (WLAN), and Wireless WMTS. The Hypervisor IX Monitoring System supports one or more Mindray compatible physiological monitors and will display, store, print, and transfer information received from the compatible monitors; The Hypervisor IX Monitoring System supports bi-directional configuration of the compatible monitors. No data processing is done by the Hypervisor IX Monitoring System for data received from compatible monitors.
The Hypervisor IX Monitoring System includes several Telemetry monitoring subsystems all of which operate in the 608M WMTS frequency range within a defined coverage area. All of the supported telemetry systems transmit data to the CentralStation for processing, display, and alarm.
· The TMS-6016 transmitter is intended for use on Adult and Pediatric patients to monitor ECG and SpO2 physiological data. The CentralStation will support ECG, Heart Rate, Arrhythmia analysis, QT monitoring, and ST Segment Analysis for the TMS-6016.
• The Panorama Telepack-608 transmitter is intended for use on Adult patients to monitor ECG and SpO2 physiological data. The Centralstation will support ECG, Heart Rate, Arrhythmia analysis, QT monitoring, and ST Segment Analysis for the Panorama Telepack-608.
· The TMS60 transmitter is intended for use on Adult and Pediatric patients to monitor ECG and SpO2 physiological data. The physiological data can be reviewed locally on the transmitter. The CentralStation will support ECG, Heart Rate, SpO2, Pulse Rate, Arrhythmia analysis, QT monitoring, and ST Segment Analysis for the TMS60.
The Hypervisor IX Monitoring System is intended for use in a hospital or other clinical environment under the direct supervision of a licensed healthcare practitioner.
Type of Use (Select one or both, as applicable)
X Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
3
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
4
510(K) SUMMARY
In accordance with 21 CFR 807.87(h) and (21 CFR 807.92) the 510(k) Summary for the Hypervisor IX Monitoring System is provided below.
| Device Common Name: | Physiological Monitors, Network and Communication
System |
|----------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Device Trade Name: | Hypervisor IX Monitoring System |
| Applicant: | SHENZHEN MINDRAY BIO-MEDICAL
ELECTRONICS CO., LTD.
Mindray Building, Keji 12th Road South
High-tech Industrial Park, Nanshan
Shenzhen 518057, P.R. China
Tel: +86 755 81885635
Fax: +86 755 26582680 |
| Contact: | Yanhong Bai
Manager Regulatory Affairs
SHENZHEN MINDRAY BIO-MEDICAL
ELECTRONICS CO., LTD.
Mindray Building, Keji 12th Road South
High-tech Industrial Park, Nanshan 518057, P.R. China
Tel: +86 755 81885635
Fax: +86 755 26582680
E-mail: baiyanhong@mindray.com |
| Prepared by: | Donna-Bea Tillman, Ph.D.
Biologics Consulting Group, Inc.
400 N. Washington St, Suite 100
Alexandria, VA 22314
Phone: 410-531-6542
Email: dtillman@bcg-usa.com |
| Date Prepared: | March 20, 2015 |
| Classification Regulation: | 870.2300 - Cardiac Monitor (including cardiotachometer and
rate alarm)
Class II |
| Panel: | Cardiovascular |
| Product Code: | MSX - Physiological Monitors Network and
Communication System |
| Subsequent Product Codes: | DRQ- Transducer signal amplifier and conditioner |
| | MHX - Arrhythmia detector and alarm (including ST-
segment measurement and alarm) |
5
K132036 – Hypervisor Central Monitoring System Predicate Device:
Indication for Use:
The indications for use of the Hypervisor IX Monitoring System include:
- Real time viewing of patient clinical data and alarms ●
- Storage and Historical review of patient clinical data and alarms ●
- Printing of real time and historical patient data ●
- Configuration of local settings as well as synchronizing settings across the network to a remote device
- Transfer of patient clinical data and settings between several CentralStations ●
The Hypervisor IX Monitoring System is a networked patient monitoring system intended for use in a fixed location, installed in a hospital or clinical environment to provide clinicians remote patient monitoring. The network connections between the various devices can be any combination of Ethernet (Wired), Wireless WiFi (WLAN), and Wireless WMTS.
The Hypervisor IX Monitoring System supports one or more Mindray compatible physiological monitors and will display, store, print, and transfer information received from the compatible monitors; The Hypervisor IX Monitoring System supports bi-directional configuration of the compatible monitors. No data processing is done by the Hypervisor IX Monitoring System for data received from compatible monitors.
The Hypervisor IX Monitoring System includes several Telemetry monitoring subsystems all of which operate in the 608M WMTS frequency range within a defined coverage area. All of the supported telemetry systems transmit data to the CentralStation for processing, display, and alarm.
- . The TMS-6016 transmitter is intended for use on Adult and Pediatric patients to monitor ECG and SpO2 physiological data. The CentralStation will support ECG, Heart Rate, SpO2, Pulse Rate, Arrhythmia analysis, QT monitoring, and ST Segment Analysis for the TMS-6016.
- . The Panorama Telepack-608 transmitter is intended for use on Adult patients to monitor ECG and SpO2 physiological data. The CentralStation will support ECG, Heart Rate, SpO2, Pulse Rate, Arrhythmia analysis, QT monitoring, and ST Segment Analysis for the Panorama Telepack-608.
- The TMS60 transmitter is intended for use on Adult and Pediatric patients to monitor ● ECG and SpO2 physiological data. The physiological data can be reviewed locally on the display of the transmitter. The CentralStation will support ECG, Heart Rate,
6
SpO2, Pulse Rate, Arrhythmia analysis, QT monitoring, and ST Segment Analysis for the TMS60.
The Hypervisor IX Monitoring System is intended for use in a hospital or other clinical environment under the direct supervision of a licensed healthcare practitioner.
Device Description:
The Hypervisor IX Monitoring System is a networked patient monitoring system intended for use in a fixed location, installed in a hospital or clinical environment to provide clinicians remote patient monitoring. The network connections between the various devices can be any combination of Ethernet (Wired), Wireless WiFi (WLAN), and Wireless WMTS.
The Hypervisor IX Monitoring System supports one or more Mindray compatible physiological monitors and will display, store, print, and transfer information received from the compatible monitors; The Hypervisor IX Monitoring System supports bi-directional configuration of the compatible monitors. No data processing is done by the Hypervisor IX Monitoring System for data received from compatible monitors.
The Hypervisor IX Monitoring System includes three telemetry monitoring systems all of which operate in the 608M WMTS frequency range within a defined coverage area. All of the supported telemetry systems transmit data to the CentralStation for processing, display, and alarm.
The Hypervisor IX Monitoring System consists the following components:
-
- Central Station
-
- View Station
-
- Work Station
-
- Telemetry Systems (TMS 6016, Telepak-608, TMS60)
Performance Data:
- . To establish the substantial equivalence of the Hypervisor IX Monitoring System, Mindray conducted functional and system level testing on the subject device. The testing provided an evaluation of the performance of the device relevant to each of the differences between the subject device and the predicate device. The functional and system level testing showed that the devices continue to meet specifications and the performance of the device is equivalent to the predicate.
- Mindray has conducted testing to ensure the subject device meets relevant consensus standards.
- . Mindray conducted Wireless functionality testing to ensure the performance of the Hypervisor IX Monitoring System meets wireless specifications and is equivalent to the predicate device.
- Mindray has followed the following FDA Guidance Documents relevant to this device:
7
- । Class II Special Controls Guidance Document: Arrhythmia Detector and Alarm Guidance for Industry and FDA (10/28/2003)
- Cardiac Monitor Guidance (Including Cardiotachometer and Rate Alarm) ।
- Class II Special Controls Guidance Document: Electrocardiograph Electrodes ।
Comparison of Technological Characteristics:
The technological characteristics of the subject device are compared to the predicate device in the table below.
| Predicate Device | Subject Device | |||
|---|---|---|---|---|
| Device Name | HYPERVISOR CENTRAL | |||
| MONITORING SYSTEM (INCLUDING | ||||
| TELEMETRY MONITORING SYSTEM, | ||||
| TMS-6016) | Hypervisor IX Monitoring System | |||
| Manufacturer | SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD | SHENZHEN MINDRAY BIO-MEDICAL | ||
| ELECTRONICS CO., LTD | ||||
| 510(k) | K132036 | TBD | ||
| Regulation | 870.2300 - Cardiac Monitor (including | |||
| cardiotachometer and rate alarm) | ||||
| Class II | 870.2300 - Cardiac Monitor (including | |||
| cardiotachometer and rate alarm) | ||||
| Class II | ||||
| Product Code | MSX - Physiological Monitors Network | |||
| and Communication System | MSX - Physiological Monitors Network | |||
| and Communication System | ||||
| Operating | ||||
| System | Windows XP Professional Embedded SP3 | Microsoft Windows 7 Professional | ||
| Embedded SP1 | ||||
| Network | ||||
| Configuration | 100 Mbps, Ethernet 802.3 | Same | ||
| Host | ||||
| Computers | HP Compaq 8380 Elite MT | HP Compaq 8380 Elite MT | ||
| HP EliteDesk 800 G1 SFF | ||||
| Kontron KISS 2U V2 KTQ87FLEX | ||||
| Patient | ||||
| Monitor | ||||
| Numbers | Up to 16 monitors in the single-screen | |||
| mode and 32 monitors in the dual- or | ||||
| multi-screen mode simultaneously | ||||
| Support up to four local displays | Same | |||
| Predicate Device | Subject Device | |||
| Patient | ||||
| Monitor | ||||
| Connectivity | Supports the following patient monitors: | |||
| DPM3 (K072235) | ||||
| DPM4/5 (K070791) | ||||
| DPM6/7 (K092449) | ||||
| Passport 12M/17M (K143195) | ||||
| Passport8/12 (K132662) | ||||
| Accutorr 7 (K132038) | ||||
| T1 (K143195) | Supports the following patient monitors: | |||
| DPM3 (K072235) | ||||
| DPM4/5 (K070791) | ||||
| DPM6/7 (K092449) | ||||
| Passport 12M/17M (K143195) | ||||
| Passport8/12 (K132662) | ||||
| Accutorr 7 (K132038) | ||||
| T1 (K143195) | ||||
| Spectrum (K062098) | ||||
| Spectrum OR (K062098) | ||||
| Passport II (K020550) | ||||
| Passport V (K091834) | ||||
| V12/21 (K132026) | ||||
| Telemetry | ||||
| System | TMS-6016 (K132036) | TMS-6016 (K132036) | ||
| Telepack-608 (K142601) | ||||
| TMS60 | ||||
| Calculations | Supports five calculation modes: | |||
| Drug Calculation | ||||
| Hemodynamics Calculation | ||||
| Oxygenation Calculation | ||||
| Ventilation Calculation | ||||
| Renal Calculation | No change | |||
| Remote | ||||
| Monitoring | Provided on supported monitors | |||
| Data Review | ||||
| Features | Dynamic short trend | |||
| Trend review | ||||
| Wave review | ||||
| NIBP review | ||||
| Event Review | ||||
| 12-lead review | ||||
| ST review | ||||
| Cardiac output review | ||||
| Print and Display | ||||
| Records | Dynamic short trend | |||
| Trend review | ||||
| Wave review | ||||
| NIBP review | ||||
| Event Review | ||||
| 12-lead review | ||||
| ST review | ||||
| Cardiac output review | ||||
| Print and Display (now includes QT View) | ||||
| Records | ||||
| Predicate Device | Subject Device | |||
| ECG Features | Mindray or Mortara ECG Algorithms - | |||
| selectable | Mindray or Mortara ECG Algorithms - | |||
| selectable | ||||
| 3-lead or 5-lead selectable | 3-lead or 5-lead selectable | |||
| arrhythmia detection | arrhythmia detection with adjustable leads | |||
| ST segment analysis | ST segment analysis | |||
| heart rate | heart rate | |||
| Pace Mark | Pace Mark | |||
| Pace Pulse Rejection | Pace Pulse Rejection | |||
| QT Analysis | ||||
| J Point Auto detection | ||||
| QRS Detection Threshold |
Device Comparison Table
8
9
Comparison of Indications:
The indication for use statement of the Hypervisor IX Monitoring System includes the indication for the system as whole as well as cleared indications for each of the components of the system. Both the predicate device and the subject device are patient monitoring systems intended to be used in healthcare facilities under the direction of clinical professionals. Additional language has been added to the indications for use of the current device to more clearly describe existing functions, as well as to include the new feature of OT monitoring. Although QT monitoring was not included in the predicate Hypervisor device, it is present in the cleared Philips ST/AR ST and Arrhythmia Software (K101521), and thus does not constitute a new intended use for a patient monitoring system.
Substantial Equivalence Conclusion:
Based on the detailed comparison of specifications for each of the modifications to the previously cleared Hypervisor Central Monitoring System, the functional and performance testing and conformance with applicable standards as well as the comparison of indications, the differences do not raise new questions of safety and effectiveness and the Hypervisor IX Monitoring System can be found substantially equivalent to the predicate device.